Marimed (MRMD) CCO Ryan Crandall Receives 32,813 Shares via RSU Vesting

What Happened
Ryan Crandall, Chief Commercial Officer of Marimed Inc. (MRMD), had 32,813 restricted stock units (RSUs) convert into common shares on July 15, 2026. Of those, 11,370 shares were withheld by the issuer to satisfy tax withholding obligations (reported at $0.07 per share, $753 total), leaving a net delivery of 21,443 shares. The conversion is reported as an exercise/conversion of a derivative (Form 4 code M) with the withholding reported under code F.

Key Details

• Transaction date: July 15, 2026; Form 4 filed July 17, 2026 (timely filing).
• Gross shares converted: 32,813; shares withheld for taxes: 11,370 @ $0.07 (reported total $753); net shares received: 21,443.
• Reported consideration: conversion/exercise price $0.00 for the RSUs (no out‑of‑pocket exercise price).
• Shares owned after transaction: not specified in the filing.
• Footnotes: F1 — RSUs convert 1:1 to common stock. F2 — withheld shares satisfy tax withholding. F3 — these RSUs were granted 4/15/2026; remaining portions vest in three equal installments on 10/15/2026, 1/15/2027 and 4/15/2027.

Context
This was a routine equity compensation vesting event (RSU conversion), not an open‑market purchase or sale of stock. The withholding of shares to cover taxes is common and does not imply a sale beyond satisfying tax obligations. The filing shows the RSU rights were converted/cancelled upon vesting and that additional tranches remain scheduled to vest. Transaction codes: M = exercise/conversion of derivative; F = tax withholding.